TP53 genetic alterations represent one of the most frequent genetic events in human malignancies, occurring in more than 50% of all cancers, including hematologic malignancies such as diffuse large B-cell lymphoma (DLBCL) [4]. Here, TP53 is linked to diffuse large B-cell lymphoma.